Daktari Diagnostics Receives $2,800,000 Series A Financing

  • Feed Type
  • Date
    9/4/2009
  • Company Name
    Daktari Diagnostics
  • Mailing Address
    Undisclosed Boston, MA 02108
  • Company Description
    Daktari Diagnostics, Inc., is a new diagnostics company focused exclusively on the most pressing challenges in global health. The company develops simple, accurate, and affordable products that deliver critical diagnostic information to clinicians and patients across the globe.
  • Website
    http://www.daktaridx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,800,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Daktari Diagnostics will use the funding to complete early development of its initial product, a revolutionary HIV point-of-care test that can perform critical, low-cost CD4 white blood cell counts to guide treatment.
  • M&A Terms
  • Venture Investor
    Partners Innovation Fund
  • Venture Investor
    Norwich Ventures
  • Venture Investor
    Launchpad Ventures
  • Venture Investor
    Hub Angels Investment Group
  • Venture Investor
    Boston Harbor Angels
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.